FDA.reportPublic FDA data

20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection

RxCUI
2374366
RxNorm name
20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection
Display name
20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection
Full name
20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AKYNZEONETUPITANT AND PALONOSETRONHelsinn Therapeutics (U.S.), Inc.8e47618e-af46-4d82-94e8-1507c042252d2026-06-23Warnings, Adverse reactionsExact identifier
rxcui: 2374366

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8e47618e-af46-4d82-94e8-1507c042252dfosnetupitant 235 MG / palonosetron 0.25 MG in 20 ML Injection [PSN] · 20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection [SCD] · fosnetupitant 235 MG (equivalent to fosnetupitant chloride HCl 260 MG) / palonosetron 0.25 MG (equivalent to palonosetron HCl 28 MG) per 20 ML Injection [SY] · fosnetupitant 235 MG / palonosetron 0.25 MG per 20 ML Injection [SY]418These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 201820260126